Acurx Pharmaceuticals, Inc. (ACXP)
Company Info
| ISIN | US00510M1045 |
|---|---|
| CUSIP | 00510M104 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $24.06M |
|---|---|
| EPS | -$1.11 |
| Year Range | $1.17 - $4.61 |
| Target Price | $11.33 |
| Short % | 0.07% |
| Short Ratio | 0.16 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Acurx Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Acurx Pharmaceuticals, Inc. had a return of -64.57% year-to-date (YTD) and -54.52% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -23.78% | -5.04% |
| 6 months | -59.13% | 4.21% |
| Year-To-Date | -64.57% | 11.29% |
| 1 year | -54.52% | 16.17% |
| 5 years (annualized) | -53.42% | 0.04% |
| 10 years (annualized) | N/A | N/A |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 4.53% | -13.58% | 3.68% | -14.52% | -23.40% | -4.93% | -22.28% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Acurx Pharmaceuticals, Inc. (ACXP) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ACXP Acurx Pharmaceuticals, Inc. | -0.88 | ||||
^GSPC S&P 500 | 1.04 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Acurx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Acurx Pharmaceuticals, Inc. is 82.13%, recorded on Sep 27, 2023. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -82.13% | Jun 28, 2021 | 565 | Sep 27, 2023 | — | — | — |
Volatility Chart
The current Acurx Pharmaceuticals, Inc. volatility is 18.87%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.